Learn more about Peter Attia’s digital program
#290 ‒ Liquid biopsies for early cancer detection, the role of epigenetics in aging, and the future of aging research | Alex Aravanis, M.D., Ph.D.
“Age is your single biggest risk factor for cancer. The population over 50 is about a 10x increased risk relative to the population under 50.” —Alex Aravanis
#213 ‒ Liquid biopsies and cancer detection | Max Diehn, M.D. Ph.D.
“I was frustrated by not being able to diagnose a recurrence earlier.” —Max Diehn
#170 – AMA #25: Navigating the complexities and nuances of cancer screening
“We screen often, we screen early, and we screen aggressively.” —Peter Attia
#133 – Vinay Prasad, M.D., M.P.H: Hallmarks of successful cancer policy
“The more you practice medicine, the more you realize that it’s an art. . .You’re going to have to make decisions today with less than perfect information.” —Vinay Prasad
#111 – AMA #14: What lab tests can (and cannot) inform us about our overall objective of longevity
“Metabolic health really matters. It is the common thread that links all of these chronic diseases.” — Peter Attia
#62 – Keith Flaherty, M.D.: Deep dive into cancer— History of oncology, novel approaches to treatment, and the exciting and hopeful future
“We can’t keep hitting the same pillar and expect that we’re going to cure cancer. . .we need the activators of the immune system, we need the inhibitors of the activated oncogenes, we need the drugs that target epigenetic regulators, and we need the metabolic switch regulators.” — Keith Flaherty
#06 – D.A. Wallach: music, medicine, longevity, and disruptive technologies
“The way that anything looks before we understand it is pretty imposing . . . when we have breakthroughs, they feel like an enormous relief, because something that seemed really complicated becomes really simple.” —D.A. Wallach